Article
A Comparative Review of Methods for Detecting Epidermal Growth Factor Receptor Mutations in Cell-free DNA from Lung Cancer Patients.
Current molecular medicine - 1 Jan 2026
Shohani Sepideh, Barati Mahmood, Hosseini Arshad
Abstract excerpt
BACKGROUND: Lung cancer remains the leading cause of cancer-related mortality. Determining the T790M resistance variants and epidermal growth factor receptor (EGFR) mutations is crucial for personalized treatment, especially when using targeted therapies. OBJECTIVE: This review article aims to comprehensively compare some of the various diagnostic techniques associated with liquid biopsies, such as cell-free DNA...
Read the complete abstract on PubMedTopics
- Humans
- Lung Neoplasms
- ErbB Receptors
- Mutation
- Cell-Free Nucleic Acids
- Liquid Biopsy
- Drug Resistance, Neoplasm
